ETNB•benzinga•
Goldman Sachs Initiates Coverage On 89bio with Neutral Rating, Announces Price Target of $11
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on March 14, 2025 by benzinga